Envista Holdings Corporation Form 8-K Summary
Business Context and Reporting Period
Envista Holdings Corporation filed a Form 8-K covering events with an earliest reported date of April 2, 2020. The filing was signed on April 8, 2020. It reports board changes and an amendment to the company’s bylaws; it does not provide operating or financial results for a reporting period.
Key Financial Metrics
The filing does not provide revenue, profit, cash flow, margins, debt, liquidity, guidance, or other operating metrics.
Material Changes
- William K. Daniel II resigned from Envista’s board on April 2, 2020.
- On April 7, 2020, the board appointed Vivek Jain, Chairman and Chief Executive Officer of ICU Medical, Inc., as a director and Audit Committee member.
- The board determined that Mr. Jain is independent under New York Stock Exchange listing standards and meets the audit committee independence requirements under Rule 10A-3.
- Mr. Jain will participate in the same compensation program as Envista’s other independent directors and entered into an indemnification agreement with Envista.
- The board amended the bylaws on April 7, 2020, adding an exclusive-forum provision designating U.S. federal district courts as the exclusive jurisdiction for litigation arising under the Securities Act of 1933.
Guidance, Risks, Contingencies, and Unusual Items
No financial guidance or management outlook is included. The exclusive-forum bylaw amendment may affect the venue for Securities Act litigation. The filing states that no arrangement or understanding existed regarding Mr. Jain’s selection and that no related-party transaction requiring disclosure under Item 404(a) was identified.
Investor Verification Items
- Review Exhibit 3.1 for the complete text and scope of the exclusive-forum bylaw amendment.
- Confirm the effective dates and implementation of Mr. Jain’s board and Audit Committee appointment.
- Review subsequent filings for additional board changes, litigation implications, or related governance developments.
- Consult the company’s periodic financial filings for revenue, profitability, cash flow, debt, liquidity, and outlook information not provided in this Form 8-K.